Patents/Assignees

ADC THERAPEUTICS SA

3 patents in portfolio

US11976122utility2024
Anti-il13rα2 Antibodies
0 cites
US11938192utility2024
Dosage Regimes for the Administration of an Anti-cd19 ADC
0 cites
US11813335utility2023
Pyrrolobenzodiazepine-antibody Conjugates
0 cites